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Abstract
Background: Under the assumption that postoperative nausea and vomiting (PONV) may occur after total hip
arthroplasty (THA) regardless of the anesthetic technique used, it is not clear whether general (GA) or spinal (SA)
anesthesia has higher causal effect on this occurrence. Conflicting results have been reported.
Methods: In this observational study, we selected all elective THA interventions performed in adults between 1999
and 2008 in a Swiss orthopedic clinic under general or spinal anesthesia. To assess the effect of anesthesia type on
the occurrence of PONV, we used the propensity score and matching methods, which allowed us to emulate the
design and results of an RCT.
Results: Among 3922 procedures, 1984 (51 %) patients underwent GA, of which 4.1 % experienced PONV, and
1938 underwent SA, of which 3.5 % experienced PONV. We found that the average treatment effect on the treated,
i.e. the effect of anesthesia type for a sample of individuals that actually received spinal anesthesia compared to
individuals who received GA, was ATET = 2.00 % [95 % CI, 0.78–3.19 %], which translated into an OR = 1.97 [95 % CI
1.35; 2.87].
Conclusion: This suggests that the type of anesthesia is not neutral regarding PONV, general anesthesia being
more strongly associated with PONV than spinal anesthesia in orthopedic surgery.
Keywords: PONV, Total hip arthroplasty, THA, General versus spinal anesthesia, Causal effect, Propensity score,
Matching
Background
Morbidity and mortality related to anesthesia have signifi-
cantly declined in recent decades [1]. While the safety and
efficacy of anesthesia procedures improved, adverse events
such as postoperative nausea and vomiting (PONV) have
become a target to further improve quality of care. PONV
may occur in 25 to 30 % of all surgery, even in 80 % for
groups at risk [2]. An optimal management of PONV is
important because they can lead to increased morbidity
including dehydration, tension on the suture lines, hyper-
tension, bleeding or even blindness [3]. PONV also influ-
ence negatively the quality of life of patients, for whom
PONV may be harder to bear than postoperative pain [4]
and cause feelings of embarrassment, humiliation or fear
of subsequent interventions [5]. All these factors may
induce a prolonged hospital stay, increase hospital re-
admission [6] and morbidity [3, 7] and thus contribute to
higher health care costs [8].
Total hip arthroplasty (THA) is a frequent operation; in
Switzerland, we counted 18,338 cases of hospitalization
for a THA in 2012 [9]. PONV is a common adverse event
in the specific context of joint arthroplasty [7]. They occur
in 20 to 80 % of total joint replacements [10, 11]. THA
surgery can be performed under general (GA), spinal (SA)
or combined anesthesia. SA is chosen increasingly [12]
because it has advantages, including a lower incidence of
deep vein thrombosis and less peri- and postoperative
* Correspondence: bernard.burnand@chuv.ch
IUMSP-Institute of Social and Preventive Medicine, Lausanne University
Hospital, Route de la Corniche 10, CH-1010 Lausanne, Switzerland
© 2016 Sansonnens et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Sansonnens et al. BMC Anesthesiology  (2016) 16:44 
DOI 10.1186/s12871-016-0207-0
blood loss [13]. We thus aimed to understand which
factors may mitigate the occurrence of PONV after
THA better. For this purpose, we used data from the
ADS (Anesthésie Données Suisse) database, a large
registry of routinely collected data in Swiss anesthesia
departments [14].
Several studies have shown that PONV is more fre-
quent and more severe during general anesthesia than
during spinal anesthesia [15, 16], while others show no
statistically significant difference [17]. General surgery
patients who underwent GA were eleven times more at
risk of experiencing PONV than patients who received
spinal anesthesia [4]. This certainly explains why the
issue of PONV is almost exclusively discussed in the
context of GA, despite the increasing proportion of SA
performed among all surgical procedures [18].
The purpose of this study was to assess the potential
causal effect of anesthesia type (general vs. spinal
anesthesia) on the occurrence of PONV in patients who
had total hip arthroplasty (THA). To our knowledge, no
other studies in anesthesiology have been performed in
Switzerland on the issue of PONV in orthopedics with
such a large number of patients.
Methods
Setting and participants
We used data collected in one orthopedic referral center
specialized in orthopedics, which performs close to
20,000 interventions each year. We selected all patients
above 18 years old who underwent anesthesia for elective
first-intention THA (which means THA as the planned
main intervention, not as a consequence or following an-
other intervention. Bilateral THA or total hip replace-
ment, i.e. replacing an old prosthesis by a new one, were
not included) performed at any time between January 1st
1999 and December 31th 2008 (the clinic ceased partici-
pating in the ADS project from that date). Patients who
have not been discharged to the recovery room, regular or
intensive care ward, or day hospital, who have been resus-
citated during surgery or up to 24 h later, who died during
surgery or within 24 h, who underwent anesthesia type
other than GA or SA (mainly combined anesthesia), with
uncommon surgeon or anesthesiologist grade or ASA sta-
tus 4, who lack information about PONV occurrence or
other variables of interest were excluded (see Fig. 1).
Data source
ADS was established in 1996 to foster quality im-
provement and for research purposes. The ADS pro-
ject, supported by the Swiss Society for Anesthesia
and Resuscitation (SSAR), offered its participants to share
data describing various aspects of processes related to
anesthesiology [14]. This database is used regularly for
research purposes [14, 19, 20].
The structure of the ADS project was modular. Each
participating department chose its level of participation,
according to its goals and interests. For every anesthetic
procedure, a standard set of core data was recorded ac-
cording to common definition and format. Optionally,
data related to management or quality were also collected.
This system has been adapted from a similar registry sys-
tem designed at the University Hospital of Trondheim,
Norway [21]. Participation to ADS was open on a volun-
tary basis to all public and private hospitals in Switzerland.
Over 40 institutions of different types and sizes partici-
pated in the project, i.e. about one fourth of all establish-
ments practicing anesthesia in the country [22]. For the
period between 1996 and 2010, more than 2 million
anesthetic acts were stored in the database.
Variables
For every procedure, the occurrence (yes or no) of an
episode of PONV was routinely recorded by member(s)
of the anesthesia team (nurse or physician) up to 24 h
after the release of the operating theatre. However, since
PONV lacks a stringent threshold-based definition, it
was reported based on clinical judgment; indeed mainly
clinically significant or important episodes may have
been recorded. Other independent variables used were:
gender, age, comorbidity indicators (allergy, angina,
arterial, arrhythmia, COPD, heart disease, cachexy, dia-
betes, bleeding diathesis, shock, hypertension, malignant
hyperthermia, infarct, infection, liver failure, renal failure,
obesity, alcoholic, endocrine system, smoking, neuro-
logical disorders, steroid treatment, non-fasting, and
asthma), ASA score, anesthetists’ and surgeons’ experience
and calendar year. Calendar year has been included into
the model to take into account temporal trends.
Data were prospectively recorded on the anesthesia
chart (paper or electronic form) and stored in each de-
partment. Anonymized data were periodically transmit-
ted securely to the data center, where they were checked
for consistency and missing values. Data were then
stored for further analysis [23].
Statistical analysis
Observational studies may lead to results that differ
from those of experimental studies, notably regarding
the occurrence of PONV after THA performed under
either SA or GA. Indeed, in an observational study, pa-
tients selected for GA generally differ from those elected
to undergo SA, thus contributing to potential selection
bias. Therefore, it is of utmost importance to adjust for
patients’ casemix when comparing PONV occurrence
rates after either GA or SA in a non randomized study.
Traditionally, standard regression methods such as logis-
tic regression analysis have been used to address this
issue. However, as we shall explain in details below,
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standard regression methods are not well suited when
the goal is to assess the causal effect [24, 25].
Traditionally, standard regression methods of the out-
come on a set of potentially confounding variables have
been used to assess the impact of an exposure (here GA
versus SA). These methods, however, often tend to pro-
vide a biased causal estimate of the exposure as they are
particularly sensitive to model misspecification, such as
misspecification of the relationship between the outcome
and the explanatory variables (e.g. assuming an overly
simplistic linear and additive relationship, omitting im-
portant variables and interactions, etc.). In addition, they
rely on strong and usually unrealistic parametric as-
sumptions [24, 25]. The key problem that generates this
model dependence is that model estimation extrapolates
over regions of the variable space where observations
are scarce and exposed and unexposed subjects not rep-
resented in the same way, i.e. the model extrapolates
over ranges of the data that do not include both exposed
and unexposed subjects and thus comparisons are very
sensitive to model misspecification.
To assess the effect of GA versus SA on the occur-
rence of PONV, we used propensity score matching, as
well as Mahalanobis distance matching (with replacement)
[26, 27]. The goal of these so-called causal methods is to
make the analyses in observational studies less model
dependent than standard regression methods. The pro-
pensity score is the conditional probability of the exposure
given a set of measured baseline covariates. Conditional
on the propensity score, the distribution of the measured
baseline covariates is similar between exposed and
unexposed subjects [26]. Likewise, Mahalanobis distance
Fig. 1 Flowchart of patients included and excluded in the study, including selection criteria
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matching allows one to balance measured baseline covari-
ates between exposed and unexposed subjects, though
somewhat more finely than propensity score matching.
The propensity score and matching methods proceed
by creating a subsample of the original data in which the
variables used to model the propensity score or used to
perform Mahalanobis matching are equally distributed
in exposed (e.g. general anesthesia) and un-exposed (e.g.
spinal anesthesia) subjects, as if the exposure had been
randomized. In this subsample it is, therefore, possible
to compute non-parametrically the contrast (e.g. risk dif-
ference (RD) or Odds Ratio (OR)) between general ver-
sus spinal anesthesia on the occurrence of PONV. Note
that balance of the unmeasured confounders will be im-
proved in so far as they are correlated with the measured
covariates included in the propensity score model.
The Mahalanobis 1-to-1 nearest-neighbor matching
method proceeds directly by finding for each exposed
individual one unexposed individual having the smallest
possible Mahalanobis distance between the vectors of
covariates, i.e. one individual whose characteristics are
closest, except on the type of anesthesia received. The
propensity score matching method proceeds, first, by
estimating the propensity score by way of the logistic
regression model, where the dependent variable is the type
of exposure (1 for general and 0 for spinal anesthesia) and
the regressors are the prognostic and confounding factors
of the relationship between exposure and outcome
(PONV, 1 yes, 0 no), then, 1-to-1 nearest-neighbor match-
ing is performed on the propensity score and for each
exposed individual an unexposed individual is selected
having the smallest possible distance between the two
propensity scores. Matching on the propensity score is
somewhat easier than matching on the vectors of covari-
ates, as it is a uni-dimensional problem, whereas the other
is multi-dimensional. It is, however, statistically less effi-
cient [28].
We computed the population average treatment effect
(ATE), which measures the contrast (i.e. RD) of the
occurrence of PONV between GA versus SA in the
whole population, as well as the average treatment effect
on the treated (ATET), which measures the contrast of
the occurrence of PONV between GA versus SA in the
subpopulation who received SA. The ATE and ATET are
two measures of the effect of a treatment or an inter-
vention commonly used in non-experimental studies
[29, 30]. The latter contrast is particularly of interest to
determine what would have happened had the patients
who received SA instead received GA.
We relied on a directed acyclic graph (DAG) to select the
appropriate variables to match on [31, 32], as shown on
Fig. 2. The difficulty with the propensity score method lies
in selecting an appropriate model so that in the matched
subsample the distributions of the covariates are balanced
between exposed and unexposed subjects. To achieve this
goal, we included into our propensity score model all the
potential confounding factors available, as well as all their
two-way interactions. However, given the very large num-
ber of variables and interactions, it was not possible to reli-
ably estimate all the regression coefficients and we selected
only the interactions whose coefficients where not too large
on the logit scale (e.g. not more than 3: higher values
were considered as artifacts) and dropped those whose
coefficient was too large (e.g. more than 3) due to the
multicollinearity and curse of dimensionality [24, 25].
The final propensity score model was selected by
checking that, on the one hand, the regression coefficients
were not overly large and, on the other hand, that the
balancing property was satisfied [33].
We computed as effect sizes the risk difference (RD)
between GA and SA, and the marginal Odds Ratio (OR)
comparing GA and SA. Notice that the marginal OR has
not to be confused with the conditional OR, which is
usually outputted by the logistic regression package. To
compute the marginal OR after standard logistic regres-
sion one must marginalize [34]. The adequacy of the
propensity score model was assessed graphically by com-
paring, after matching, on the one hand the distributions
-
-
Fig. 2 DAG of the presumed causal relationship between exposure (type of anesthesia) and outcome (PONV)
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of the estimated propensity scores for those who received
GA and those who received SA, and on the other hand
the distributions of the covariates included into the pro-
pensity score model. All the analyses were performed
using STATA software 64-bit version 13.1.
Results
A total of 4873 procedures meeting our inclusion criteria
were available in the database. After applying our exclusion
criteria and discarding lines with missing values we were
left with 3922 patients. Out of these patients 1984 (51 %)
underwent GA, and 1938 (49 %) SA. Irrespective of the
type of anesthesia, an episode of PONV was observed as a
single post-anesthetic event in 93 cases, and concomitantly
with one or other events in 56 cases, resulting in a total of
149 cases (3.8 %). Patients’ characteristics are summarized
in Table 1.
We calculated the crude odds ratio (GA vs. SA), which
was OR = 1.2 95 % CI [0.87; 1.67], see Table 2.
After matching, the two distributions of the propensity
scores were very similar in those who underwent SA
(blue line) and GA (red line) (see Fig. 3).
Using the propensity score matching estimator, we
found that the average treatment effect on the treated
was ATET = 2.00 % with 95 % CI [0.78–3.19 %], which
translates into an OR = 1.97, 95 % CI [1.35; 2.87], whereas
with the Mahalanobis matching estimator we found
ATET = 2.10 %, 95 % CI [0.90 %; 3.39 %], which translates
into an OR = 2.10, 95 % CI [1.44; 3.12].
Regarding the average treatment effect for the 3922
patients, using the propensity score matching estimator
we found ATE = 1.20 %, 95 % CI [−0.04 %; 2.49 %], which
translates into an OR = 1.46, 95 % CI [1.14; 1.87], whereas
with the Mahalanobis matching estimator we found
ATE = 1.50 %, 95 % CI [−0.05 %; 2.96 %], which translates
into an OR = 1.60, 95 % CI [1.22; 2.00]. Therefore, the risk
of experiencing PONV was 1.5 ~ 2 -fold higher among
patients under GA compared to patients under SA; these
result show statistical and clinical significance.
Finally, with the standard logistic regression model
including the same explanatory variables as in the pro-
pensity score model, as well as the interactions between
them, the marginal OR was 1.12, 95 % CI [0.89; 1.41],
which is considerably smaller than what we found using
causal methods.
Discussion
Relying on the registry, we found that 4.1 % of patients
undergoing THA under GA and 3.5 % under SA experi-
enced PONV. These proportions are in line with Singe-
lyn et al. [35] who considered total hip replacement and
reported PONV’s prevalences of 3, 4, and 7 % depending
on the anesthetic technique used.
Our study showed a clear advantage of SA over GA
for patients who underwent THA. Had those who re-
ceived SA had had GA instead, the risk of PONV occur-
rence would have increased by about 2 %. Likewise, had
everybody received GA compared to SA, the occurrence
of PONV would have increased by about 1.5 %. Other
studies have found contradictory results. The study from
Wulf et al. [36], which compared epidural vs. general
anesthesia in the perioperative management of hip re-
placement concluded that PONV was more common
with GA, whereas Harsten et al. [37] and Fischer et al.
[38] concluded the opposite. However, these studies did
not use a causal methodology. Further work, ideally with
RCTs, is required to clarify this issue. Nevertheless, our
Table 1 Patients’ characteristics (age, gender, ASA score, type of anesthesia and median duration of anesthesia) crossed with PONV
experience status (yes/no)
Patients’ characteristics Total (n = 3922) Experienced PONV (n = 149) Did not experience PONV (n = 3773)
Age (average ± SD) 64.2 (SD = 12.1) 63.8 (SD = 11.8) 64.2 (SD = 12.1)
Female 49.6 % 71.2 % 49.6 %
ASA score
1 13.4 % 12.8 % 13.4 %
2 60.5 % 61.7 % 60.5 %
3 26.1 % 25.5 % 26.1 %
Type of anesthesia
GA 50.6 % 55.0 % 50.4 %
SA 49.4 % 45.0 % 49.6 %
Median duration of anesthesia (min) 171.4 172.4 171.4
Table 2 Crude odds ratio between type of anesthesia and
PONV experience status
Crude odds ratio GA SA Total
Experienced PONV 82 67 149
Did not experienced PONV 1902 1871 3773
Total 1984 1938 3922
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results clearly indicate that for patients undergoing a
THA intervention under GA the incidence of PONV
was higher than under SA.
Using the standard logistic regression model with the
same regressors as those included into the propensity score
model, it was not possible to identify the increased risk of
PONV for GA. We found an OR of 1.12, 95 % CI [0.89;
1.41], which was small and non-statistically significant.
This may be due to a misspecification of the functional
form for the linear predictor or the omission of important
confounders or interactions. The great advantages of the
matching methods are that they are largely nonparametric.
Our study, however, bears several limitations. Pre-
operative nausea, particularly transient nausea just after
spinal anesthesia injection due to drop in blood pressure,
has not been taken into account due to lack of informa-
tion. Potential, uncorrelated confounders may exist that
were not routinely recorded in ADS. The data have been
collected over an extended period of 10 years, and it is
likely that anesthetic techniques or drugs available to
anesthesiologists have changed during this period. As
shown by other authors, type of induction and/or main-
tenance agent influence the risk of PONV [39]. Using a
randomized controlled trial of 1180 children and adults
at high risk for PONV scheduled for elective surgery,
Apfel et al. [40] concluded that in the early postoperative
period, the leading risk factor for vomiting was the use
of volatile anaesthetics. In the postoperative period, the
use of postoperative opioids was an important predictor
for vomiting. Unfortunately, these informations were not
available within the ADS database. We nevertheless
somehow indirectly accounted for them by adjusting for
calendar year in the propensity score model. We could
not determine if any of the patients in the general
anesthesia group had any regional anesthesia for postop
pain control, as this information was not collected in the
registry. Antiemetic premedication was not collected ei-
ther, and therefore the inclusion of patients who received
such drugs may have introduced some bias. Demographic
changes, including the aging of the population who under-
went anesthesia [14], were not taken into account. It also
should be noted that the quality of the collected data is
likely to vary among years (depending on the turnover),
although a previous study [14] showed good general qual-
ity of the ADS data. Despite a standardized definition,
PONV detection relies heavily on clinical judgment, which
potentially introduces an element of inter-individual and
inter-hospital variability that has not yet been evaluated.
Our study also bears strengths. We used data extracted
from a registry of prospectively mandatory reported pre
and postoperative adverse events. Several studies have
shown that the prevalence of self-reported events on a
voluntary basis is generally underestimated [41–43], and
such underestimation occurs irrespective of the type of
anesthesia [42]. We used routinely collected data for our
analyses. Studies has shown that routine data are at least
as relevant to the analysis of the quality of care that clin-
ical data collected for this purpose [44, 45], while being
more cost-effective [46]. Our single-center study included
3922 acts of anesthesia, recorded over a period of 10 years,
which is substantial. As a sensitivity analysis, we used
two different causal methods, namely propensity score
matching and Mahalanobis matching, to estimate different
causal parameters (the population average treatment effect
and the average treatment effect on the treated). The re-
sults were qualitatively the same and allowed us to identify
Fig. 3 Distributions of the propensity scores after matching between SA and GA patients subgroups
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a higher risk of PONV for GA versus SA; whereas this was
not the case using standard logistic regression analysis.
Actually, the latter is much more sensitive to misspecifica-
tion of the model, such as the wrong functional form for
the continuous regressors or missed interactions. Finally,
unlike an RCT, our research reflects the actual daily prac-
tice of anesthesia.
Conclusions
Using causal propensity score methods our study showed
that the occurrence of PONV side effects during THA
interventions was about 2 % lower for SA than for GA, a
result that was not identifiable using standard regression
methods only. Our results are of clinical importance given
the large number of such interventions performed. Com-
pared to other studies which included fewer patients [17],
this study adds generalizability.
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